CBS 2019
CBSMD教育中心
English

急性冠脉综合征

科研文章

荐读文献

Galectin-3 Levels and Outcomes After Myocardial Infarction: A Population-Based Study Complete Revascularization During Primary Percutaneous Coronary Intervention Reduces Death and Myocardial Infarction in Patients With Multivessel Disease-Meta-Analysis and Meta-Regression of Randomized Trials Inflammatory Bowel Disease and Acute Coronary Syndromes: From Pathogenesis to the Fine Line Between Bleeding and Ischemic Risk Ticagrelor versus Clopidogrel in Patients with STEMI Treated with Fibrinolytic Therapy: TREAT Trial Association of Silent Myocardial Infarction and Sudden Cardiac Death An EAPCI Expert Consensus Document on Ischaemia with Non-Obstructive Coronary Arteries in Collaboration with European Society of Cardiology Working Group on Coronary Pathophysiology & Microcirculation Endorsed by Coronary Vasomotor Disorders International Study Group Epinephrine Versus Norepinephrine for Cardiogenic Shock After Acute Myocardial Infarction Association Between Collateral Circulation and Myocardial Viability Evaluated by Cardiac Magnetic Resonance Imaging in Patients With Coronary Artery Chronic Total Occlusion Open sesame technique in percutaneous coronary intervention for ST-elevation myocardial infarction Prognostic value of fibrinogen in patients with coronary artery disease and prediabetes or diabetes following percutaneous coronary intervention: 5-year findings from a large cohort study
|<<... 16 17 18 19 20 21 22 ...>>|

Editorial2019 Jan 15;139(3):347-350.

JOURNAL：Circulation. Article Link

Percutaneous Support Devices for Percutaneous Coronary Intervention

Patel MR. Keywords: drug-eluting stents; STEMI without cardiogenic shock ; myocardial reperfusion; percutaneous coronary intervention; percutaneous support devices

FULL TEXT PDF

>CBS CBS 2019

> CBS 2019

> CBS 2019 注册

> CBS 2019 会议日程

> CBS 2019 学术征集

> CBS 2019 热点

 CBSMD

> CBSMD 网站注册

> 教育中心

> 荐读文献

> Top 10 阅读文献

> 文献导读
CBS 2019 CBS 2019 主席团 教育中心 科研动态
Copyright ⓒ CBS MD Nanjing China. All rights reserved. 京ICP备16025898号-11
联系我们| Top